Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers.
Cammack AJ, Atassi N, Hyman T, van den Berg LH, Harms M, Baloh RH, Brown RH, van Es MA, Veldink JH, de Vries BS, Rothstein JD, Drain C, Jockel-Balsarotti J, Malcolm A, Boodram S, Salter A, Wightman N, Yu H, Sherman AV, Esparza TJ, McKenna-Yasek D, Owegi MA, Douthwright C; Alzheimer's Disease Neuroimaging Initiative; McCampbell A, Ferguson T, Cruchaga C, Cudkowicz M, Miller TM.
Cammack AJ, et al. Among authors: douthwright c.
Neurology. 2019 Oct 22;93(17):e1605-e1617. doi: 10.1212/WNL.0000000000008359. Epub 2019 Oct 2.
Neurology. 2019.
PMID: 31578300
Free PMC article.
The monthly change was -1.8 1.7 for ALS Functional Rating Scale-Revised and -1.4% 3.24% of predicted for slow vital capacity. ...We found that clinical features of this genetic subset are less variant than in singleton ALS. In addition, we identified important corre …
The monthly change was -1.8 1.7 for ALS Functional Rating Scale-Revised and -1.4% 3.24% of predicted for slow vital capacity. ...We f …